|
Cord Blood Registry’s Newborn Possibilities Program
PR Newswire (press release) For families that have been identified with a qualifying medical condition currently treatable with a cord blood stem cell transplant or a high-risk pregnancy, the Newborn Possibilities Program provides no-cost newborn stem cell processing and five … |
Samsung unveils Galaxy S5 in India, available from April 11 – Times of India
Times of India |
Samsung unveils Galaxy S5 in India, available from April 11
Times of India The device has a 2800mAh battery. The three key features in Galaxy S5 are finger-print scanner, a heart-rate sensor and the new body that is water and dust proof. In the market, Galaxy S5 will go against the next generation of top end smartphones from … Samsung Gear Fit, Gear 2, and Gear 2 Neo India price revealedNDTV Samsung Galaxy S5 Launched in India; Price, Specification DetailsInternational Business Times, India Edition Samsung Galaxy S5 price in India between Rs 51000-Rs 53000, to be available …BGR India IBNLive –Daily News & Analysis –Businessworld all 510 news articles » |
RuiYi Announces $15 Million Series B to Advance Pipeline of Therapeutic … – MarketWatch
|
RuiYi Announces $15 Million Series B to Advance Pipeline of Therapeutic …
MarketWatch RuiYi has a pipeline of innovative monoclonal antibodies to previously untargeted G protein coupled receptors (GPCRs) for important global, therapeutic needs. The financing will support the continued development of RuiYi’s lead asset, RYI-008, a novel … San Diego’s RuiYi Raises $15M for Pipeline of Biologic TherapeuticsXconomy RuiYi banks $15M from A-list backers to amp up Chinese R&DFierceBiotech |
Johns Hopkins researchers use 3-D MRI scans to accurately measure tumor … – News-Medical.net
|
Johns Hopkins researchers use 3-D MRI scans to accurately measure tumor …
News-Medical.net All were treated with surgery or liver transplantation after chemoembolization. The research team used existing MR analysis techniques, as well as the new 3-D method to compare the radiologists’ analyses with pathologic review of tumor samples after … |
Galloway Introduces Monica's Bill for Living Organ Donor Tax Deduction – Insurance News Net (press release)
|
Galloway Introduces Monica’s Bill for Living Organ Donor Tax Deduction
Insurance News Net (press release) … behalf of Pennsylvania State Rep. John Galloway, D- Bucks, has introduced legislation that would provide for a personal state tax deduction for uncovered expenses incurred by a living organ donor during the organ donor process. Her part in the … |
Final NICE backing for MabThera in rare condition – PMLiVE
Final NICE backing for MabThera in rare conditionPMLiVEThe National Institute for Heath and Care Excellence (NICE) issued final guidance this week that gave the green light for MabThera (rituximab) to treat adults with a rare condition known as anti-ne…
Pollution in the house causes twice the number of deaths as outdoor air pollution! – India.Com Health
India.Com Health |
Pollution in the house causes twice the number of deaths as outdoor air pollution!
India.Com Health lungs Quitting smoking may not be enough to improve your lung function if your cooking fuel is not clean and ventilation in the kitchen is not proper, research says. ‘Substituting biogas for biomass fuel for cooking and improving kitchen ventilation … |
Stop fretting over the smelly underarms – Times of India
Times of IndiaStop fretting over the smelly underarmsTimes of India… as well as deodorants and antiperspirants available in the market and still suffer from armpit stink, the cause can be something more serious. Persistent body odour can be a sign th…
Event celebrates organ donation – Fond du Lac Reporter
Event celebrates organ donationFond du Lac ReporterSherry Linzmeier with a photo of her son Dan, who was killed in a 1996 car crash. Organs and tissue from Dan helped save 48 people. / Submitted photo. Written by. For Action Reporter Media. Filed Under…
What is Nice? Drugs body Q&A – Telegraph.co.uk
Telegraph.co.uk |
What is Nice? Drugs body Q&A
Telegraph.co.uk Last March it rejected Afinitor (everolimus), which costs about £36,000 a time on grounds of cost, saying there was no evidence it was better than treatments already available. :: At the same time the body turned down Inlyta (axitinib) for kidney … |